We are live on
!
Find out more
GIM
Groesbeck Investment Management Portfolio holdings
AUM
$62.8M
1-Year Est. Return
52.32%
This Fund
S&P 500
This Quarter
Est. Return
+8.49%
1 Year Est. Return
+52.32%
3 Year Est. Return
+146.85%
5 Year Est. Return
+188.49%
10 Year Est. Return
+524.09%
AUM
$241M
AUM Growth
+$9.85M
(+4.3%)
Cap. Flow
-$6.24M
Cap. Flow
% of AUM
-2.59%
Top 10 Holdings %
Top 10 Hldgs %
30.99%
Holding
85
New
13
Increased
9
Reduced
43
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
QCOR
QUESTCOR PHARMA INC
QCOR
|
+$5.36M |
| 2 |
CVR Energy
CVI
|
+$3.29M |
| 3 |
Visa
V
|
+$2.67M |
| 4 |
GNC
GNC Holdings, Inc.
GNC
|
+$2.48M |
| 5 |
Nu Skin
NUS
|
+$2.28M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enterprise Products Partners
EPD
|
+$3.32M |
| 2 |
Ecolab
ECL
|
+$3.24M |
| 3 |
Eli Lilly
LLY
|
+$2.69M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
+$2.55M |
| 5 |
Procter & Gamble
PG
|
+$2.34M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.16% |
| 2 | Healthcare | 14.63% |
| 3 | Consumer Discretionary | 13.04% |
| 4 | Energy | 12.29% |
| 5 | Consumer Staples | 10.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Wells Fargo
WFC
$265B
| $241K | 0.1% |
5,300
| – | – |
|
77
Capri Holdings
CPRI
$1.75B
| $237K | 0.1% |
+2,915
| New | +$230K |
|
78
McCormick & Company Non-Voting
MKC
$14.3B
| $234K | 0.1% |
6,804
-8,200
| -55% | -$280K |
|
79
Intel
INTC
$492B
| $232K | 0.1% |
8,928
-17,004
| -66% | -$411K |
|
|
EMC
80
DELISTED
EMC CORPORATION
EMC
| $211K | 0.09% |
8,400
| – | – |
|
81
American Tower
AMT
$78.8B
| $208K | 0.09% |
+2,600
| New | +$202K |
|
|
FISV
82
Fiserv Inc
FISV
$27.8B
| – | – |
-30,752
| Closed | -$777K |
|
|
83
Procter & Gamble
PG
$340B
| – | – |
-30,928
| Closed | -$2.34M |
|
84
Ulta Beauty
ULTA
$23.6B
| – | – |
-1,690
| Closed | -$202K |
|
|
LLL
85
DELISTED
L3 Technologies, Inc.
LLL
| – | – |
-26,975
| Closed | -$2.55M |
|
Similar funds
1I
AIM
BGPJL
HFCIV
CIR
LC
HPCM
KC
Groesbeck Investment Management's Q4 2013 Portfolio in Review
As of Q4 2013, Groesbeck Investment Management held 85 positions worth $241M, up 4.3% from $231M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Groesbeck Investment Management's Q4 2013 filing shows 13 new, 9 increased, 43 reduced and 4 closed positions. Its largest new stake was QUESTCOR PHARMA INC: 90,774 shares worth $4.94M. The largest sale was Enterprise Products Partners, an estimated $3.32M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Groesbeck Investment Management's largest Q4 2013 buy was QUESTCOR PHARMA INC: 90,774 shares worth $4.94M.
- Groesbeck Investment Management added most to GNC Holdings, Inc. in Q4 2013, an estimated $2.48M increase.
- Groesbeck Investment Management's biggest Q4 2013 reduction was Enterprise Products Partners, cutting an estimated $3.32M.
- Groesbeck Investment Management fully exited L3 Technologies, Inc. in Q4 2013, selling an estimated $2.55M.
- Groesbeck Investment Management's ten largest holdings make up 31% of its $241M portfolio in Q4 2013.
- Groesbeck Investment Management opened 13 new positions and closed 4 in Q4 2013.
- Groesbeck Investment Management's portfolio value rose 4.3% quarter-over-quarter to $241M.
Based on Groesbeck Investment Management's 13F filing for Q4 2013, filed 11 Feb 2014.